{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:28:17Z","timestamp":1787930897147,"version":"build-2784847793"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02349-5","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:38:25Z","timestamp":1784795905000},"page":"5013-5030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing"],"prefix":"10.1007","volume":"34","author":[{"given":"Sheer A.","family":"Joodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia A.","family":"Nawwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora O. Abdel","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weam W.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmy M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2349_CR1","doi-asserted-by":"publisher","first-page":"124372","DOI":"10.1016\/j.lfs.2026.124372","volume":"395","author":"NM El Abdelrheem","year":"2026","unstructured":"Abdelrheem NM, Ahmed MA, Mohamed AF, El Sayed NS, Shalaby HN (2026) Anti-inflammatory and antinociceptive effects of fasudil in a reserpine-induced fibromyalgia model: role of ROCK-regulated leptin\u2013STAT3 signaling. Life Sci 395:124372","journal-title":"Life Sci"},{"issue":"3","key":"2349_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1517\/14728214.2010.491509","volume":"15","author":"JN Ablin","year":"2010","unstructured":"Ablin JN, Buskila D (2010) Emerging therapies for fibromyalgia: an update. Expert Opin Emerg Drugs 15(3):521\u2013533","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"2349_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/pmt-2016-0007","volume":"6","author":"JN Ablin","year":"2016","unstructured":"Ablin JN, H\u00e4user W (2016) Fibromyalgia syndrome: novel therapeutic targets. Pain Manage 6(4):371\u2013381","journal-title":"Pain Manage"},{"issue":"23","key":"2349_CR4","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3390\/cells13231986","volume":"13","author":"HA Abotaleb","year":"2024","unstructured":"Abotaleb HA, Alturkistani HA, Abd El-Aziz GS, Hindi EA, Halawani MM, Al-Thepyani MA, Alghamdi BS (2024) The antinociceptive effects and sex-specific neurotransmitter modulation of metformin in a mouse model of fibromyalgia. Cells 13(23):1986","journal-title":"Cells"},{"key":"2349_CR5","doi-asserted-by":"publisher","first-page":"118623","DOI":"10.1016\/j.jep.2024.118623","volume":"335","author":"AS Aboutaleb","year":"2024","unstructured":"Aboutaleb AS, Allam A, Zaky HS, Harras MF, Farag FSA-A, Abdel-Sattar SA, El-Said NT, Ahmed HI (2024) Novel insights into the molecular mechanisms underlying anti-nociceptive effect of myricitrin against reserpine-induced fibromyalgia model in rats: implication of SIRT1 and miRNAs. J Ethnopharmacol 335:118623and F. M. Abd El-Mordy","journal-title":"J Ethnopharmacol"},{"key":"2349_CR6","doi-asserted-by":"crossref","unstructured":"Aker DA, \u00d6ke D (2025) Is vortioxetine as preferable a molecule as duloxetine in depressed patients with fibromyalgia? In: Annales M\u00e9dico-psychologiques, revue psychiatrique. Elsevier","DOI":"10.1016\/j.amp.2025.09.004"},{"key":"2349_CR7","doi-asserted-by":"publisher","first-page":"178408","DOI":"10.1016\/j.ejphar.2025.178408","volume":"1010","author":"TM Al-Matarneh","year":"2025","unstructured":"Al-Matarneh TM, El-Said YA, Ibrahim WW, El-Tanbouly DM (2025) Targeting kynurenine pathway and A1\/A2 astrocytes polarization in experimentally induced fibromyalgia: modulatory role of apigenin on kynurenine\/aryl hydrocarbon receptor signaling. Eur J Pharmacol 1010:178408","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2349_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s11682-015-9459-4","volume":"10","author":"DS Albrecht","year":"2016","unstructured":"Albrecht DS, MacKie PJ, Kareken DA, Hutchins GD, Chumin EJ, Christian BT, Yoder KK (2016) Differential dopamine function in fibromyalgia. Brain imaging Behav 10(3):829\u2013839","journal-title":"Brain imaging Behav"},{"issue":"7","key":"2349_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.bbadis.2015.03.005","volume":"1852","author":"E Alcocer-G\u00f3mez","year":"2015","unstructured":"Alcocer-G\u00f3mez E, Garrido-Maraver J, Bull\u00f3n P, Mar\u00edn-Aguilar F, Cot\u00e1n D, Carri\u00f3n AM, Alvarez-Suarez JM, Giampieri F, S\u00e1nchez-Alcazar JA, Battino M (2015) Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from fibromyalgia patients. Biochim et Biophys Acta (BBA)-Mol Basis Dis. 1852(7):1257\u20131267","journal-title":"Biochim et Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"10","key":"2349_CR10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1080\/03007995.2019.1629757","volume":"35","author":"LM Arnold","year":"2019","unstructured":"Arnold LM, Whitaker S, Hsu C, Jacobs D, Merante D (2019) Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo-and active-controlled, parallel-group studies and a 52-week open-label extension study. Curr Med Res Opin 35(10):1825\u20131835","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2349_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/13548506.2023.2216464","volume":"29","author":"NN Aslan \u00c7\u0130n","year":"2024","unstructured":"Aslan \u00c7\u0130n NN, A\u00e7ik M, Tertem\u0130z OF, Aktan \u00c7, Ak\u00e7ali DT, \u00c7akiro\u011flu FP, \u00d6z\u00e7el\u0130k A\u00d6 (2024) Effect of prebiotic and probiotic supplementation on reduced pain in patients with fibromyalgia syndrome: a double-blind, placebo-controlled randomized clinical trial. Psychol health Med 29(3):528\u2013541","journal-title":"Psychol health Med"},{"issue":"3","key":"2349_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10787-023-01216-x","volume":"31","author":"AA Atta","year":"2023","unstructured":"Atta AA, Ibrahim WW, Mohamed AF, Abdelkader NF (2023a) Microglia polarization in nociplastic pain: mechanisms and perspectives. Inflammopharmacology 31(3):1053\u20131067","journal-title":"Inflammopharmacology"},{"key":"2349_CR13","doi-asserted-by":"publisher","first-page":"175810","DOI":"10.1016\/j.ejphar.2023.175810","volume":"952","author":"AA Atta","year":"2023","unstructured":"Atta AA, Ibrahim WW, Mohamed AF, Abdelkader NF (2023b) Targeting \u03b17-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: involvement of cAMP\/PKA, PI3K\/AKT, and M1\/M2 microglia polarization. Eur J Pharmacol 952:175810","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2349_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12035-025-05585-y","volume":"63","author":"M Belviranl\u0131","year":"2026","unstructured":"Belviranl\u0131 M, Okudan N, Sezer T (2026a) Coenzyme Q10 ameliorates fibromyalgia-like symptoms and cognitive deficits by enhancing hippocampal PGC-1\u03b1\/FNDC5\/BDNF pathway in reserpine-treated rats. Mol Neurobiol 63(1):248","journal-title":"Mol Neurobiol"},{"key":"2349_CR15","doi-asserted-by":"publisher","first-page":"124366","DOI":"10.1016\/j.lfs.2026.124366","volume":"394","author":"M Belviranl\u0131","year":"2026","unstructured":"Belviranl\u0131 M, Okudan N, Sezer T (2026b) Coenzyme Q10 improves redox homeostasis, mitochondrial biogenesis, and irisin signaling in fast-and slow-twitch muscle fibers in a reserpine-induced fibromyalgia-like myalgia model. Life Sci 394:124366","journal-title":"Life Sci"},{"issue":"7","key":"2349_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","volume":"114","author":"RM Bennett","year":"2003","unstructured":"Bennett RM, Kamin M, Karim R, Rosenthal N (2003) Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114(7):537\u2013545","journal-title":"Am J Med"},{"issue":"10","key":"2349_CR17","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/head.14991","volume":"65","author":"S Braca","year":"2025","unstructured":"Braca S, Russo CV, Stornaiuolo A, Cretella G, Miele A, Giannini C, De Simone R (2025) Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high\u2010frequency or chronic migraine: a prospective pilot study. Headache: J Head Face Pain 65(10):1831\u20131838","journal-title":"Headache: J Head Face Pain"},{"issue":"4","key":"2349_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/JCP.0b013e31829057ae","volume":"33","author":"A Bruno","year":"2013","unstructured":"Bruno A, Mic\u00f2 U, Lorusso S, Cogliandro N, Pandolfo G, Caminiti M, Zoccali RA, Muscatello MR (2013) Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. J Clin Psychopharmacol 33(4):507\u2013511","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"2349_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3344\/kjp.25275","volume":"39","author":"KD Bruun","year":"2026","unstructured":"Bruun KD, Nielsen MJ, Vaegter HB, Blichfeldt-Eckhardt MR, Amris K, Pedersen JR (2026) Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported. Korean J Pain 39(1):140\u2013143","journal-title":"Korean J Pain"},{"issue":"3","key":"2349_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/ars.2014.6120","volume":"24","author":"P Bull\u00f3n","year":"2016","unstructured":"Bull\u00f3n P, Alcocer-G\u00f3mez E, Carri\u00f3n AM, Mar\u00edn-Aguilar F, Garrido-Maraver J, Rom\u00e1n-Malo L, Ruiz-Cabello J, Culic O, Ryffel B, Apetoh L (2016) AMPK phosphorylation modulates pain by activation of NLRP3 inflammasome. Antioxid Redox Signal 24(3):157\u2013170","journal-title":"Antioxid Redox Signal"},{"key":"2349_CR21","doi-asserted-by":"crossref","unstructured":"Cai W, Haddad M, Haddad R, Kesten I, Hoffman T, Laan R, Westfall S, Defaye M, Abdullah NS, Wong C (2025) Gut microbiota promotes pain fibromyalgia. Neuron 113(13):2161\u20132175 e2113","DOI":"10.1016\/j.neuron.2025.03.032"},{"issue":"1","key":"2349_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2474-12-95","volume":"12","author":"EP Calandre","year":"2011","unstructured":"Calandre EP, Morillas-Arques P, Molina-Barea R, Rodriguez-Lopez CM, Rico-Villademoros F (2011) Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskelet Disord 12(1):95","journal-title":"BMC Musculoskelet Disord"},{"issue":"02","key":"2349_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1055\/s-0033-1363659","volume":"47","author":"E Calandre","year":"2014","unstructured":"Calandre E, Slim M, Garcia-Leiva J, Rodriguez-Lopez C, Torres P, Rico-Villademoros F (2014) Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study. Pharmacopsychiatry 47(02):67\u201372","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"2349_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jab.2018.01.005","volume":"16","author":"MY Casta\u00f1o","year":"2018","unstructured":"Casta\u00f1o MY, Garrido M, Delgado-Ad\u00e1mez J, Martillanes S, G\u00f3mez M\u00c1, Rodr\u00edguez AB (2018) Oral melatonin administration improves the objective and subjective sleep quality, increases 6-sulfatoxymelatonin levels and total antioxidant capacity in patients with fibromyalgia. J Appl Biomed 16(3):186\u2013191","journal-title":"J Appl Biomed"},{"issue":"1","key":"2349_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1099800418811634","volume":"21","author":"MY Casta\u00f1o","year":"2019","unstructured":"Casta\u00f1o MY, Garrido M, Rodr\u00edguez AB, G\u00f3mez M\u00c1 (2019) Melatonin improves mood status and quality of life and decreases cortisol levels in fibromyalgia. Biol Res Nurs 21(1):22\u201329","journal-title":"Biol Res Nurs"},{"key":"2349_CR26","doi-asserted-by":"publisher","first-page":"205873841983838","DOI":"10.1177\/2058738419838383","volume":"33","author":"E Cavalli","year":"2019","unstructured":"Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E (2019) The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J ImmunoPathol Pharmacol 33:2058738419838383","journal-title":"Int J ImmunoPathol Pharmacol"},{"issue":"10","key":"2349_CR27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/pm\/pnaa303","volume":"21","author":"C Chaves","year":"2020","unstructured":"Chaves C, Bittencourt PCT, Pelegrini A (2020) Ingestion of a THC-rich cannabis oil in people with fibromyalgia: a randomized, double-blind, placebo-controlled clinical trial. Pain Med 21(10):2212\u20132218","journal-title":"Pain Med"},{"key":"2349_CR28","doi-asserted-by":"publisher","first-page":"138464","DOI":"10.1016\/j.neulet.2025.138464","volume":"871","author":"J Chen","year":"2025","unstructured":"Chen J, Lai Y, Li W (2025) Involvement of substance P\/NK1 receptor system in central sensitization in chronic pain. Neurosci Lett 871:138464","journal-title":"Neurosci Lett"},{"issue":"4","key":"2349_CR29","doi-asserted-by":"publisher","first-page":"115406","DOI":"10.1016\/j.isci.2026.115406","volume":"29","author":"S Chen","year":"2026","unstructured":"Chen S, Shanmuganathan D, Imlach WL (2026) Microbiome-derived metabolites alleviate chronic pain in a reserpine-induced model of fibromyalgia. iScience 29(4):115406","journal-title":"iScience"},{"issue":"1","key":"2349_CR30","doi-asserted-by":"publisher","first-page":"103424","DOI":"10.1016\/j.autrev.2023.103424","volume":"23","author":"D Clauw","year":"2024","unstructured":"Clauw D, Sarzi-Puttini P, Pellegrino G, Shoenfeld Y (2024) Is fibromyalgia an autoimmune disorder? Autoimmun rev 23(1):103424","journal-title":"Autoimmun rev"},{"issue":"11\u201312","key":"2349_CR33","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.nut.2012.03.018","volume":"28","author":"MD Cordero","year":"2012","unstructured":"Cordero MD, Cot\u00e1n D, del-Pozo-Mart\u00edn Y, Carri\u00f3n AM, de Miguel M, Bull\u00f3n P, S\u00e1nchez-Alcazar JA (2012) Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition 28(11\u201312):1200\u20131203","journal-title":"Nutrition"},{"key":"2349_CR32","unstructured":"Cordero MD, Alcocer-G\u00f3mez E, De Miguel M, Culic O, Carri\u00f3n AM, Alvarez-Suarez JM, Bull\u00f3n P, Battino M, Fern\u00e1ndez-Rodr\u00edguez A, S\u00e1nchez-Alcazar JA (2013) Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? SAGE Publications, Los Angeles, CA"},{"issue":"8","key":"2349_CR31","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/ars.2013.5198","volume":"20","author":"MD Cordero","year":"2014","unstructured":"Cordero MD, Alcocer-G\u00f3mez E, Culic O, Carri\u00f3n AM, De Miguel M, D\u00edaz-Parrado E, P\u00e9rez-Villegas EM, Bull\u00f3n P, Battino M, S\u00e1nchez-Alcazar JA (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 20(8):1169\u20131180","journal-title":"Antioxid Redox Signal"},{"key":"2349_CR34","unstructured":"Corp TPH (2025) Tonix pharmaceuticals announces FDA approval of Tonmya\u2122(cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia"},{"key":"2349_CR35","first-page":"1465","volume":"5","author":"R Corrigan","year":"2012","unstructured":"Corrigan R, Derry S, Wiffen PJ, Moore RA (2012) Clonazepam for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 5:1465\u20131858","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2349_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/bja\/aen088","volume":"101","author":"R D\u2019Mello","year":"2008","unstructured":"D\u2019Mello R, Dickenson AH (2008) Spinal cord mechanisms of pain. Br J Anaesth 101(1):8\u201316","journal-title":"Br J Anaesth"},{"issue":"12","key":"2349_CR37","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.3390\/ijms22126471","volume":"22","author":"R D\u2019Amico","year":"2021","unstructured":"D\u2019Amico R, Fusco R, Siracusa R, Impellizzeri D, Peritore AF, Gugliandolo E, Interdonato L, Sforza AM, Crupi R, Cuzzocrea S (2021) Inhibition of P2X7 purinergic receptor ameliorates fibromyalgia syndrome by suppressing NLRP3 pathway. Int J Mol Sci 22(12):6471","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2349_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s42358-024-00393-9","volume":"64","author":"JF de Carvalho","year":"2024","unstructured":"de Carvalho JF, de Sena EP (2024) Ketamine in fibromyalgia: a systematic review. Adv Rheumatol 64(1):54","journal-title":"Adv Rheumatol"},{"issue":"1","key":"2349_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/2050-6511-15-40","volume":"15","author":"SA de Zanette","year":"2014","unstructured":"de Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, Xavier F, de Souza ICC, Deitos A, Torres IL (2014) Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol 15(1):40","journal-title":"BMC Pharmacol Toxicol"},{"issue":"14","key":"2349_CR40","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3390\/nu17142261","volume":"17","author":"G Dipalma","year":"2025","unstructured":"Dipalma G, Marinelli G, Ferrante L, Di Noia A, Carone C, Colonna V, Marotti P, Inchingolo F, Palermo A, Tartaglia GM (2025) Modulating the gut microbiota to target neuroinflammation, cognition and mood: a systematic review of human studies with relevance to fibromyalgia. Nutrients 17(14):2261","journal-title":"Nutrients"},{"issue":"3","key":"2349_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s13311-020-00905-7","volume":"17","author":"CR Donnelly","year":"2020","unstructured":"Donnelly CR, Andriessen AS, Chen G, Wang K, Jiang C, Maixner W, Ji R-R (2020) Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics 17(3):846\u2013860","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2349_CR42","first-page":"3985154","volume":"2018","author":"M Ernberg","year":"2018","unstructured":"Ernberg M, Christidis N, Ghafouri B, Bileviciute-Ljungar I, L\u00f6fgren M, Bjersing J, Palstam A, Larsson A, Mannerkorpi K, Gerdle B (2018) Plasma cytokine levels in fibromyalgia and their response to 15 weeks of progressive resistance exercise or relaxation therapy. Mediat Inflamm 2018(1):3985154","journal-title":"Mediat Inflamm"},{"key":"2349_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbi.2023.09.003","volume":"114","author":"S Fanton","year":"2023","unstructured":"Fanton S, Menezes J, Krock E, Sandstr\u00f6m A, Tour J, Sandor K, Jurczak A, Hunt M, Baharpoor A, Kadetoff D (2023) Anti-satellite glia cell IgG antibodies in fibromyalgia patients are related to symptom severity and to metabolite concentrations in thalamus and rostral anterior cingulate cortex. Brain Behav Immun 114:371\u2013382","journal-title":"Brain Behav Immun"},{"issue":"7","key":"2349_CR44","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/ijms18071389","volume":"18","author":"G Favero","year":"2017","unstructured":"Favero G, Trapletti V, Bonomini F, Stacchiotti A, Lavazza A, Rodella LF, Rezzani R (2017) Oral supplementation of melatonin protects against fibromyalgia-related skeletal muscle alterations in reserpine-induced myalgia rats. Int J Mol Sci 18(7):1389","journal-title":"Int J Mol Sci"},{"key":"2349_CR45","doi-asserted-by":"publisher","first-page":"113552","DOI":"10.1016\/j.biopha.2022.113552","volume":"154","author":"EG Ferrarini","year":"2022","unstructured":"Ferrarini EG, Paes RS, Baldasso GM, de Assis PM, Gouv\u00eaa MC, De Cicco P, Raposo NRB, Capasso R, Moreira ELG, Dutra RC (2022) Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in mice. Biomed Pharmacother 154:113552","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2349_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/brainsci15020206","volume":"15","author":"K Findeisen","year":"2025","unstructured":"Findeisen K, Guymer E, Littlejohn G (2025) Neuroinflammatory and immunological aspects of fibromyalgia. Brain Sci 15(2):206","journal-title":"Brain Sci"},{"issue":"12","key":"2349_CR47","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/antiox8120628","volume":"8","author":"R Fusco","year":"2019","unstructured":"Fusco R, Siracusa R, D\u2019Amico R, Peritore AF, Cordaro M, Gugliandolo E, Crupi R, Impellizzeri D, Cuzzocrea S, Di Paola R (2019) Melatonin plus folic acid treatment ameliorates reserpine-induced fibromyalgia: an evaluation of pain, oxidative stress, and inflammation. Antioxidants 8(12):628","journal-title":"Antioxidants"},{"key":"2349_CR49","doi-asserted-by":"crossref","unstructured":"Garc\u00eda R\u00edos MD, Navarro Ledesma S, Tapia Haro RM, Toledano-Moreno S, Casas Barrag\u00e1n A, Correa Rodr\u00edguez M, Aguilar Ferrandiz ME (2019) Ferrandiz Effectiveness of health education in patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med 55(2):301-313","DOI":"10.23736\/S1973-9087.19.05524-2"},{"issue":"S1","key":"2349_CR48","doi-asserted-by":"publisher","first-page":"S149a","DOI":"10.1016\/S1090-3801(09)60506-1","volume":"13","author":"J Garcia-Leiva","year":"2009","unstructured":"Garcia-Leiva J, Molina\u2010Barea R, Rodriguez\u2010Lopez CM, Morillas\u2010Arques P, Garcia\u2010Carrillo J, Calandre E (2009) 503 ropinirole in the treatment of refractory fibromyalgia: a case series. Eur J Pain 13(S1):S149a\u2013S149","journal-title":"Eur J Pain"},{"issue":"12","key":"2349_CR50","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s11916-024-01277-9","volume":"28","author":"V Giorgi","year":"2024","unstructured":"Giorgi V, Sarzi-Puttini P, Pellegrino G, Sirotti S, Atzeni F, Alciati A, Torta R, Varrassi G, Fornasari D, Coaccioli S (2024) Pharmacological treatment of fibromyalgia syndrome: a practice-based review. Curr Pain Headache Rep 28(12):1349\u20131363","journal-title":"Curr Pain Headache Rep"},{"issue":"13","key":"2349_CR51","doi-asserted-by":"publisher","first-page":"e144201","DOI":"10.1172\/JCI144201","volume":"131","author":"A Goebel","year":"2021","unstructured":"Goebel A, Krock E, Gentry C, Israel MR, Jurczak A, Urbina CM, Sandor K, Vastani N, Maurer M, Cuhadar U (2021) Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Investig 131(13):e144201","journal-title":"J Clin Investig"},{"key":"2349_CR52","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Flores D, L\u00f3pez-Pingarr\u00f3n L, Casta\u00f1o MY, G\u00f3mez M\u00c1, Rodr\u00edguez AB, Garc\u00eda JJ, Garrido M (2023) Melatonin as a coadjuvant in the treatment of patients with fibromyalgia. Biomedicines 11(7): 1964","DOI":"10.3390\/biomedicines11071964"},{"issue":"3","key":"2349_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/01.j.pain.0000460333.79127.be","volume":"156","author":"RB Griggs","year":"2015","unstructured":"Griggs RB, Donahue RR, Morgenweck J, Grace PM, Sutton A, Watkins LR, Taylor BK (2015) Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPAR\u03b3 mechanisms. Pain 156(3):469\u2013482","journal-title":"Pain"},{"key":"2349_CR54","doi-asserted-by":"crossref","unstructured":"Gyorfi M, Rupp A, Abd-Elsayed A (2022) Fibromyalgia pathophysiology. Biomedicines 10(12):3070","DOI":"10.3390\/biomedicines10123070"},{"issue":"9","key":"2349_CR55","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41583-020-0333-z","volume":"21","author":"M Hanani","year":"2020","unstructured":"Hanani M, Spray DC (2020) Emerging importance of satellite glia in nervous system function and dysfunction. Nat Rev Neurosci 21(9):485\u2013498","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2349_CR57","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/07853890.2021.1916069","volume":"53","author":"FE Hassan","year":"2021","unstructured":"Hassan FE, Sakr HI, Mohie PM, Suliman HS, Mohamed AS, Attia MH, Eid DM (2021) Pioglitazone improves skeletal muscle functions in reserpine-induced fibromyalgia rat model. Ann Med 53(1):1033\u20131041","journal-title":"Ann Med"},{"issue":"3","key":"2349_CR56","first-page":"282","volume":"45","author":"FE Hassan","year":"2025","unstructured":"Hassan FE, Eid DM, Aldreny BA (2025) Glucagon-like peptide-1 agonist and Quercetin improve skeletal muscle performance and pain threshold in male rats with fibromyalgia via activating the Nrf2\/HO1\/NQO1 pathway. Bull Egypt Soc Physiological Sci 45(3):282\u2013295","journal-title":"Bull Egypt Soc Physiological Sci"},{"key":"2349_CR58","doi-asserted-by":"publisher","first-page":"1593908","DOI":"10.3389\/fpain.2025.1593908","volume":"6","author":"T Ho","year":"2025","unstructured":"Ho T, Ryan M, Holle J (2025) Redox reactions in chronic pain: mechanisms and relevance in fibromyalgia. Front Pain Res 6:1593908","journal-title":"Front Pain Res"},{"issue":"8","key":"2349_CR59","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.21191","volume":"52","author":"AJ Holman","year":"2005","unstructured":"Holman AJ, Myers RR (2005) A randomized, double-blind, placebo\u2010controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheumatism: Official J Am Coll Rheumatol 52(8):2495\u20132505","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"issue":"1","key":"2349_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1300\/J094v12n01_10","volume":"12","author":"AJ Holman","year":"2004","unstructured":"Holman AJ, Neiman RA, Ettlinger RE (2004) Preliminary efficacy of the dopamine agonist, pramipexole, for fibromyalgia: the first, open label, multicenter experience. J Musculoskelet Pain 12(1):69\u201374","journal-title":"J Musculoskelet Pain"},{"key":"2349_CR61","doi-asserted-by":"publisher","first-page":"106976","DOI":"10.1016\/j.jff.2025.106976","volume":"132","author":"I-H Hsiao","year":"2025","unstructured":"Hsiao I-H, Hsu H-C, Liao H-Y, Huang H-M, Lin Y-W (2025) Eicosapentaenoic acid reduces fibromyalgia pain by inhibiting the microglia\/astrocyte and toll-like receptor 4 pathway in the mouse brain. J Funct Foods 132:106976","journal-title":"J Funct Foods"},{"key":"2349_CR62","first-page":"7868","volume":"87","author":"SFZ Hujjat","year":"2025","unstructured":"Hujjat SFZ, Zahra SH, Abbas T, Kalam H (2025) Tonmya (cyclobenzaprine hydrochloride sublingual tablets): first FDA-approved therapy for fibromyalgia in over 15 years. LWW 87:7868\u20137869","journal-title":"LWW"},{"key":"2349_CR64","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-3-33","volume":"3","author":"R-R Ji","year":"2007","unstructured":"Ji R-R, Suter MR (2007) p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3:17448069-1743-1733","journal-title":"Mol Pain"},{"issue":"11","key":"2349_CR63","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","volume":"20","author":"R-R Ji","year":"2019","unstructured":"Ji R-R, Donnelly CR, Nedergaard M (2019) Astrocytes in chronic pain and itch. Nat Rev Neurosci 20(11):667\u2013685","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"2349_CR65","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3892\/etm.2016.3643","volume":"12","author":"H Jia","year":"2016","unstructured":"Jia H, Xu S, Liu Q, Liu J, Xu J, Li W, Jin Y, Ji Q (2016) Effect of pioglitazone on neuropathic pain and spinal expression of TLR-4 and cytokines. Experimental therapeutic Med 12(4):2644\u20132650","journal-title":"Experimental therapeutic Med"},{"key":"2349_CR66","doi-asserted-by":"publisher","first-page":"137397","DOI":"10.1016\/j.neulet.2023.137397","volume":"812","author":"F Jing","year":"2023","unstructured":"Jing F, Zou Q, Pu Y (2023) GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model. Neurosci Lett 812:137397","journal-title":"Neurosci Lett"},{"key":"2349_CR67","doi-asserted-by":"crossref","unstructured":"Jones EA, Asaad F, Patel N, Jain E, Abd-Elsayed A (2024) Manage fibromyalgia: update. Biomedicines 12(6):1266","DOI":"10.3390\/biomedicines12061266"},{"key":"2349_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-024-01608-7","volume":"33","author":"SA Joodi","year":"2025","unstructured":"Joodi SA, Ibrahim WW, Khattab MM (2025) Drugs repurposing in the experimental models of Alzheimer\u2019s disease. Inflammopharmacology 33:1\u201320","journal-title":"Inflammopharmacology"},{"key":"2349_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2014.01.007","volume":"562","author":"K Kaneko","year":"2014","unstructured":"Kaneko K, Umehara M, Homan T, Okamoto K, Oka M, Oyama T (2014) The analgesic effect of tramadol in animal models of neuropathic pain and fibromyalgia. Neurosci Lett 562:28\u201333","journal-title":"Neurosci Lett"},{"issue":"3","key":"2349_CR70","first-page":"31","volume":"10","author":"S Khalid","year":"2015","unstructured":"Khalid S, Soomro BA, Mahmood Z (2015) Efficacy of memantine in treating patients with fibromyalgia. Pakistan J Neurol Sci (PJNS) 10(3):31\u201336","journal-title":"Pakistan J Neurol Sci (PJNS)"},{"issue":"3","key":"2349_CR71","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/j.pain.0000000000001448","volume":"160","author":"IA Khasabova","year":"2019","unstructured":"Khasabova IA, Khasabov SG, Olson JK, Uhelski ML, Kim AH, Albino-Ram\u00edrez AM, Wagner CL, Seybold VS, Simone DA (2019) Pioglitazone, a PPAR\u03b3 agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress. Pain 160(3):688\u2013701","journal-title":"Pain"},{"key":"2349_CR72","doi-asserted-by":"publisher","first-page":"109800","DOI":"10.1016\/j.jnutbio.2024.109800","volume":"136","author":"E Kilinc","year":"2025","unstructured":"Kilinc E, Torun IE, Kilinc YB, T\u00f6re F (2025) Proposed receptor-mediated mechanisms of melatonin in nitroglycerin-induced migraine-like hyperalgesic conditions in rats. J Nutr Biochem 136:109800","journal-title":"J Nutr Biochem"},{"issue":"4","key":"2349_CR73","doi-asserted-by":"publisher","first-page":"420","DOI":"10.13107\/jocr.2026.v16.i04.7166","volume":"16","author":"MM Kishore","year":"2026","unstructured":"Kishore MM, Jeyaraman M, Jeyaraman N, Nallakumarasamy A, Bharadwaj S (2026) Implications of gut microbiome in fibromyalgia: a scoping review. J Orthop Case Rep 16(4):420","journal-title":"J Orthop Case Rep"},{"issue":"8","key":"2349_CR74","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/j.pain.0000000000002881","volume":"164","author":"E Krock","year":"2023","unstructured":"Krock E, Morado-Urbina CE, Menezes J, Hunt MA, Sandstr\u00f6m A, Kadetoff D, Tour J, Verma V, Kultima K, Haglund L (2023) Fibromyalgia patients with elevated levels of anti\u2013satellite glia cell immunoglobulin G antibodies present with more severe symptoms. Pain 164(8):1828\u20131840","journal-title":"Pain"},{"issue":"5","key":"2349_CR75","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/life13051160","volume":"13","author":"P-C Lai","year":"2023","unstructured":"Lai P-C, Yen C-M, Lin M-C, Chen Y-H, Liao H-Y, Huang Y-W, Lin Y-W (2023) Electroacupuncture attenuates fibromyalgia pain via toll-like receptor 4 in the mouse brain. Life 13(5):1160","journal-title":"Life"},{"issue":"2","key":"2349_CR76","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.euroneuro.2015.12.007","volume":"26","author":"K Ledermann","year":"2016","unstructured":"Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C (2016) Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression\u2013A [11\u00a0C] raclopride PET-study. Eur Neuropsychopharmacol 26(2):320\u2013330","journal-title":"Eur Neuropsychopharmacol"},{"issue":"22","key":"2349_CR77","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/cells13221857","volume":"13","author":"S-O Lee","year":"2024","unstructured":"Lee S-O, Kuthati Y, Huang W-H, Wong C-S (2024) Semaglutide ameliorates diabetic neuropathic pain by inhibiting neuroinflammation in the spinal cord. Cells 13(22):1857","journal-title":"Cells"},{"issue":"7","key":"2349_CR78","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.7150\/thno.19500","volume":"7","author":"J-J Lin","year":"2017","unstructured":"Lin J-J, Lin Y, Zhao T-Z, Zhang C-K, Zhang T, Chen X-L, Ding J-Q, Chang T, Zhang Z, Sun C (2017) Melatonin suppresses neuropathic pain via MT2-dependent and-independent pathways in dorsal root ganglia neurons of mice. Theranostics 7(7):2015","journal-title":"Theranostics"},{"issue":"3","key":"2349_CR79","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12264-022-00961-3","volume":"39","author":"H-J Lu","year":"2023","unstructured":"Lu H-J, Gao Y-J (2023) Astrocytes in chronic pain: cellular and molecular mechanisms. Neurosci Bull 39(3):425\u2013439","journal-title":"Neurosci Bull"},{"issue":"5","key":"2349_CR80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.31083\/j.jin2305089","volume":"23","author":"Y Ma","year":"2024","unstructured":"Ma Y, Kang Y-q, Shi W-y, Ji W-m, Zhou, Nan W (2024) The complexity of neuropathic pain and central sensitization: exploring mechanisms and therapeutic prospects. J Integr Neurosci 23(5):89","journal-title":"J Integr Neurosci"},{"issue":"2","key":"2349_CR81","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, H\u00e4user W, Flu\u00df E, Choy E, Kosek E, Amris K, Branco J (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76(2):318\u2013328","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2349_CR82","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4103\/1673-5374.317984","volume":"17","author":"CP Martins","year":"2022","unstructured":"Martins CP, Paes RS, Baldasso GM, Ferrarini EG, Scussel R, Zaccaron RP, Machado-de-\u00c1vila RA, Silveira PCL, Dutra RC (2022) Pramipexole, a dopamine D3\/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice. Neural Regeneration Res 17(2):450\u2013458","journal-title":"Neural Regeneration Res"},{"issue":"5","key":"2349_CR83","first-page":"313","volume":"49","author":"A Mehramiri","year":"2024","unstructured":"Mehramiri A, Shalilahmadi D, Mohamadianinejad SE, Kouti L, Hosseinpour Y (2024) The effect of melatonin on reducing the frequency and severity of migraine attacks: a double-blind, randomized clinical trial. Iran J Med Sci 49(5):313","journal-title":"Iran J Med Sci"},{"issue":"9","key":"2349_CR84","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00296-022-05135-y","volume":"42","author":"P Mehta","year":"2022","unstructured":"Mehta P, Basu A, Ahmed S (2022) Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort. Rheumatol Int 42(9):1549\u20131554","journal-title":"Rheumatol Int"},{"key":"2349_CR85","doi-asserted-by":"crossref","unstructured":"Minerbi A, Gonzalez E, Brereton NJ, Anjarkouchian A, Dewar K, Fitzcharles M-A, Chevalier S, Shir Y (2019) Altered microbiome composition individuals fibromyalgia. Pain 160(11):2589\u20132602","DOI":"10.1097\/j.pain.0000000000001640"},{"issue":"1","key":"2349_CR86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11481-025-10207-4","volume":"20","author":"MM Mohamed","year":"2025","unstructured":"Mohamed MM, Zaki HF, Kamel AS (2025) Possible interaction of suramin with thalamic P2X receptors and NLRP3 inflammasome activation alleviates reserpine-induced fibromyalgia-like symptoms. J Neuroimmune Pharmacol 20(1):51","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"2349_CR87","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2474-11-204","volume":"11","author":"P Morillas-Arques","year":"2010","unstructured":"Morillas-Arques P, Rodriguez-Lopez CM, Molina-Barea R, Rico-Villademoros F, Calandre EP (2010) Trazodone for the treatment of fibromyalgia: an open-label, 12-week study. BMC Musculoskelet Disord 11(1):204","journal-title":"BMC Musculoskelet Disord"},{"key":"2349_CR88","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/JPR.S285609","volume":"14","author":"C Mueller","year":"2021","unstructured":"Mueller C, Ness TJ, Younger JW (2021) Low-dose dextromethorphan for the treatment of fibromyalgia pain: results from a longitudinal, single-blind, placebo-controlled pilot trial. J Pain Res 14:189\u2013200","journal-title":"J Pain Res"},{"key":"2349_CR89","doi-asserted-by":"publisher","first-page":"172750","DOI":"10.1016\/j.ejphar.2019.172750","volume":"865","author":"N Murai","year":"2019","unstructured":"Murai N, Kondo Y, Akuzawa S, Mihara T, Shiraishi N, Kakimoto S, Matsumoto M (2019) A novel GABAB receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia. Eur J Pharmacol 865:172750","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2349_CR90","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s43440-020-00103-4","volume":"72","author":"H Murasawa","year":"2020","unstructured":"Murasawa H, Kobayashi H, Yasuda S-i, Saeki K, Domon Y, Arakawa N, Kubota K, Kitano Y (2020) Anxiolytic-like effects of mirogabalin, a novel ligand for \u03b12\u03b4 ligand of voltage-gated calcium channels, in rats repeatedly injected with acidic saline intramuscularly, as an experimental model of fibromyalgia. Pharmacol Rep 72(3):571\u2013579","journal-title":"Pharmacol Rep"},{"key":"2349_CR91","doi-asserted-by":"publisher","first-page":"111647","DOI":"10.1016\/j.biopha.2021.111647","volume":"139","author":"H Murasawa","year":"2021","unstructured":"Murasawa H, Pawlak A, Kobayashi H, Saeki K, Yasuda S-i, Kitano Y (2021) Mirogabalin, a novel ligand for \u03b12\u03b4 subunit of voltage-gated calcium channels, improves cognitive impairments in repeated intramuscular acidic saline injection model rats, an experimental model of fibromyalgia. Biomed Pharmacother 139:111647","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2349_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/her\/cyy055","volume":"34","author":"G Musekamp","year":"2019","unstructured":"Musekamp G, Gerlich C, Ehlebracht-K\u00f6nig I, Dorn M, H\u00f6fter A, Tomiak C, Schlittenhardt D, Faller H, Reusch A (2019) Evaluation of a self-management patient education programme for fibromyalgia\u2014results of a cluster-RCT in inpatient rehabilitation. Health Educ Res 34(2):209\u2013222","journal-title":"Health Educ Res"},{"issue":"3","key":"2349_CR93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pmn.2024.11.007","volume":"26","author":"EB Okul","year":"2025","unstructured":"Okul EB, Fertelli TK (2025) The effects of sleep hygiene education on sleep quality, pain, and depression in individuals with fibromyalgia. Pain Manage Nurs 26(3):282\u2013289","journal-title":"Pain Manage Nurs"},{"issue":"12","key":"2349_CR94","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","volume":"155","author":"B Olivan-Bl\u00e1zquez","year":"2014","unstructured":"Olivan-Bl\u00e1zquez B, Herrera-Mercadal P, Puebla-Guedea M, P\u00e9rez-Yus M-C, Andr\u00e9s E, Fayed N, L\u00f3pez-Del-Hoyo Y, Magallon R, Roca M, Garcia-Campayo J (2014) Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up. PAIN\u00ae 155(12):2517\u20132525","journal-title":"PAIN\u00ae"},{"issue":"1","key":"2349_CR95","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11481-025-10274-7","volume":"21","author":"J Osama","year":"2026","unstructured":"Osama J, El-Gazar AA, Ragab GM, El-Sayed NS, Kamel AS (2026) Melatonin mitigates central sensitization and nociplastic pain in spinal cord and dorsal root ganglia of FM rat model: modulation of SIRT1\/PGC-1\u03b1\/MAPK\/NF-\u03baB signaling. J Neuroimmune Pharmacol 21(1):12","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"2349_CR96","doi-asserted-by":"publisher","first-page":"e15021","DOI":"10.1111\/1756-185X.15021","volume":"27","author":"JF Palma-Ord\u00f3\u00f1ez","year":"2024","unstructured":"Palma-Ord\u00f3\u00f1ez JF, Moreno\u2010Fern\u00e1ndez AM, Ram\u00edrez\u2010Tejero JA, Dur\u00e1n\u2010Gonz\u00e1lez E, Mart\u00ednez\u2010Lara A, Cot\u00e1n D (2024) Implication of intestinal microbiota in the etiopathogenesis of fibromyalgia: a systematic review. Int J Rheum Dis 27(1):e15021","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"2349_CR97","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biomedicines5020016","volume":"5","author":"L Parkitny","year":"2017","unstructured":"Parkitny L, Younger J (2017) Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia. Biomedicines 5(2):16","journal-title":"Biomedicines"},{"issue":"11","key":"2349_CR98","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.3390\/ijms25115922","volume":"25","author":"M Paroli","year":"2024","unstructured":"Paroli M, Gioia C, Accapezzato D, Caccavale R (2024) Inflammation, autoimmunity, and infection in fibromyalgia: a narrative review. Int J Mol Sci 25(11):5922","journal-title":"Int J Mol Sci"},{"key":"2349_CR100","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/JPR.S127288","volume":"10","author":"WL Pridgen","year":"2017","unstructured":"Pridgen WL, Duffy C, Gendreau JF, Gendreau RM (2017) A famciclovir+ celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia. J Pain Res 10:451\u2013460","journal-title":"J Pain Res"},{"key":"2349_CR99","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2021-eular.1424","volume":"80","author":"W Pridgen","year":"2021","unstructured":"Pridgen W, Duffy C, Gendreau J, Gendreau R (2021) POS0017 IMC-1, a fixed dose combination of famciclovir and celecoxib, improves common symptoms associated with fibromyalgia in addition to pain: post hoc analysis of a phase 2A trial. Ann Rheum Dis 80:210","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2349_CR101","doi-asserted-by":"publisher","first-page":"e70321","DOI":"10.1002\/ejp.70321","volume":"30","author":"C Rodr\u00edguez-Freire","year":"2026","unstructured":"Rodr\u00edguez-Freire C, Navarrete J, Rozadilla\u2010Sacanell A, Sanabria\u2010Mazo JP, del Pino\u2010Gaya B, Borr\u00e0s X, Feliu\u2010Soler A, Luciano JV (2026) Efficacy of low\u2010dose naltrexone in women with fibromyalgia syndrome: a 12\u2010month randomised, double\u2010blind, placebo\u2010controlled single\u2010centre clinical trial (INNOVA study). Eur J Pain 30(6):e70321","journal-title":"Eur J Pain"},{"issue":"11","key":"2349_CR103","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, Mackillip F (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthr Rhuem 37(11):1593\u20131601","journal-title":"Arthr Rhuem"},{"issue":"5","key":"2349_CR102","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.pain.2010.12.022","volume":"152","author":"IJ Russell","year":"2011","unstructured":"Russell IJ, Holman AJ, Swick TJ, Alvarez-Horine S, Wang YG, Guinta D, Group SO-FS (2011) Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 152(5):1007\u20131017","journal-title":"Pain"},{"issue":"8","key":"2349_CR104","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.3390\/molecules26082398","volume":"26","author":"K Sa\u0142at","year":"2021","unstructured":"Sa\u0142at K, Furga\u0142a-Wojas A (2021) Serotonergic neurotransmission system modulator, vortioxetine, and dopaminergic D2\/D3 receptor agonist, ropinirole, attenuate fibromyalgia-like symptoms in mice. Molecules 26(8):2398","journal-title":"Molecules"},{"issue":"1","key":"2349_CR105","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2009.05345.x","volume":"1193","author":"P Sarzi-Puttini","year":"2010","unstructured":"Sarzi-Puttini P, Atzeni F, Cazzola M (2010) Neuroendocrine therapy of fibromyalgia syndrome: an update. Ann N Y Acad Sci 1193(1):91\u201397","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"2349_CR106","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/10715762.2019.1645955","volume":"53","author":"P Sawaddiruk","year":"2019","unstructured":"Sawaddiruk P, Apaijai N, Paiboonworachat S, Kaewchur T, Kasitanon N, Jaiwongkam T, Kerdphoo S, Chattipakorn N, Chattipakorn SC (2019) Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction. Free Radic Res 53(8):901\u2013909","journal-title":"Free Radic Res"},{"issue":"8","key":"2349_CR107","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/j.pain.0000000000003535","volume":"166","author":"S Seefried","year":"2025","unstructured":"Seefried S, Barcic A, Yepez MFG, Reinhardt L, Appeltshauser L, Doppler K, \u00dc\u00e7eyler N, Sommer C (2025) Autoantibodies in patients with fibromyalgia syndrome. Pain 166(8):1922\u20131933","journal-title":"Pain"},{"issue":"1","key":"2349_CR108","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11481-025-10196-4","volume":"20","author":"MZ Shafiek","year":"2025","unstructured":"Shafiek MZ, Zaki HF, Mohamed AF, Ibrahim WW (2025) Novel trajectories towards possible effects of semaglutide for amelioration of reserpine-induced fibromyalgia in rats: contribution of cAMP\/PKA\/p-CREB and M1\/M2 microglia polarization. J Neuroimmune Pharmacol 20(1):43","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"2349_CR109","first-page":"165","volume":"39","author":"V Shukla","year":"2020","unstructured":"Shukla V, Kumar DS, Ali MA, Agarwal S, Khandpur S (2020) Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity. J Med Biochem 39(2):165","journal-title":"J Med Biochem"},{"issue":"Supplement 1","key":"2349_CR110","first-page":"31","volume":"3","author":"K Si\u0107ovi\u0107","year":"2024","unstructured":"Si\u0107ovi\u0107 K, Nasti\u0107 K, Pecikoza U, Micov A (2024) Semaglutide exhibits antihyperalgesic effects in an animal model of chronic migraine. Neurosci Appl 3(Supplement 1):31\u201331","journal-title":"Neurosci Appl"},{"issue":"8","key":"2349_CR111","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms22083891","volume":"22","author":"R Siracusa","year":"2021","unstructured":"Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D (2021) Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 22(8):3891","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2349_CR112","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF02229708","volume":"15","author":"A Sivri","year":"1996","unstructured":"Sivri A, Cinda\u015f A, Dincer F, Sivri B (1996) Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol 15(3):283\u2013286","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2349_CR113","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","volume":"9","author":"RQ Skrabek","year":"2008","unstructured":"Skrabek RQ, Galimova L, Ethans K, Perry D (2008) Nabilone for the treatment of pain in fibromyalgia. J Pain 9(2):164\u2013173","journal-title":"J Pain"},{"issue":"6","key":"2349_CR114","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/annrheumdis-2011-200418","volume":"71","author":"M Spaeth","year":"2012","unstructured":"Spaeth M, Bennett RM, Benson BA, Wang YG, Lai C, Choy EH (2012) Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. Ann Rheum Dis 71(6):935\u2013942","journal-title":"Ann Rheum Dis"},{"key":"2349_CR115","doi-asserted-by":"crossref","unstructured":"Tripathi V, Mishra A, Pathak Y, Jain A, Prakash H (2020) Pathogenic role of iNOs+ M1 effector macrophages in fibromyalgia. In: Macrophages, IntechOpen","DOI":"10.5772\/intechopen.94492"},{"issue":"4","key":"2349_CR116","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3344\/kjp.24202","volume":"37","author":"AD Vatvani","year":"2024","unstructured":"Vatvani AD, Patel P, Hariyanto TI, Yanto TA (2024) Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Korean J Pain 37(4):367\u2013378","journal-title":"Korean J Pain"},{"key":"2349_CR117","doi-asserted-by":"publisher","first-page":"1782714","DOI":"10.3389\/fmed.2026.1782714","volume":"13","author":"T Wang","year":"2026","unstructured":"Wang T, Su H, Zhou Y, Du L, Lv Y, Yu L (2026) Effects of exercise on pain, fatigue, and quality of life in people with fibromyalgia: a systematic review and meta-analysis of randomized controlled trials. Front Med 13:1782714","journal-title":"Front Med"},{"issue":"2","key":"2349_CR118","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","volume":"110","author":"MA Ware","year":"2010","unstructured":"Ware MA, Fitzcharles M-A, Joseph L, Shir Y (2010) The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analgesia 110(2):604\u2013610","journal-title":"Anesth Analgesia"},{"key":"2349_CR119","first-page":"1465","volume":"11","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, Lunn MP, Hamunen K, Haanpaa M, Kalso EA (2013) Antiepileptic drugs for neuropathic pain and fibromyalgia-an overview of cochrane reviews. Cochrane Database Syst Rev 11:1465\u20131858","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2349_CR121","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62(5):600\u2013610","journal-title":"Arthritis Care Res"},{"key":"2349_CR120","doi-asserted-by":"crossref","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, H\u00e4user W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B (2016) 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Seminars in arthritis and rheumatism. Elsevier","DOI":"10.1016\/j.semarthrit.2016.08.012"},{"key":"2349_CR123","doi-asserted-by":"publisher","first-page":"811584","DOI":"10.3389\/fphar.2021.811584","volume":"12","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhou W, Xu X, Ge X, Wang F, Zhang G-Q, Miao L, Deng X (2022) Aprepitant inhibits JNK and p38\/MAPK to attenuate inflammation and suppresses inflammatory pain. Front Pharmacol 12:811584","journal-title":"Front Pharmacol"},{"key":"2349_CR122","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/JPR.S395457","volume":"16","author":"J Yang","year":"2023","unstructured":"Yang J, Shin K-M, Do A, Bierle DM, Abu Dabrh AM, Yin Z, Bauer BA, Mohabbat AB (2023) The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review. J Pain Res 16:1017\u20131023","journal-title":"J Pain Res"},{"key":"2349_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuroscience.2023.10.005","volume":"534","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Fang Q, Chen J, Wang Y, Liu X, Zhang X, Shi Y, Zhan H, Zhong X, Yao M (2023) Melatonin improves mitochondrial dysfunction and attenuates neuropathic pain by regulating SIRT1 in dorsal root ganglions. Neuroscience 534:29\u201340","journal-title":"Neuroscience"},{"key":"2349_CR125","doi-asserted-by":"publisher","first-page":"1109938","DOI":"10.3389\/fimmu.2022.1109938","volume":"13","author":"X Zhan","year":"2023","unstructured":"Zhan X, Li Q, Xu G, Xiao X, Bai Z (2023) The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors. Front Immunol 13:1109938","journal-title":"Front Immunol"},{"issue":"3","key":"2349_CR126","doi-asserted-by":"publisher","first-page":"108416","DOI":"10.1016\/j.jdiacomp.2023.108416","volume":"37","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang Q, Bai Y, Zheng H, Ji L, Zhu X, Sun W, Liu X, Zhang S, Li Y (2023) Glycogen synthesis kinase-3\u03b2 involves in the analgesic effect of liraglutide on diabetic neuropathic pain. J Diabetes Complicat 37(3):108416","journal-title":"J Diabetes Complicat"},{"key":"2349_CR127","doi-asserted-by":"publisher","first-page":"116856","DOI":"10.1016\/j.biopha.2024.116856","volume":"176","author":"L Zhao","year":"2024","unstructured":"Zhao L, Tao X, Wang K, Song Y, Zhang B, Yang L, Wang Z (2024) Astaxanthin alleviates fibromyalgia pain and depression via NLRP3 inflammasome inhibition. Biomed Pharmacother 176:116856","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2349_CR128","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3344\/kjp.2021.34.1.47","volume":"34","author":"L Zhu","year":"2021","unstructured":"Zhu L, Huang Y, Hu Y, Tang Q, Zhong Y (2021) Toll-like receptor 4\/nuclear factor-kappa B pathway is involved in radicular pain by encouraging spinal microglia activation and inflammatory response in a rat model of lumbar disc herniation. Korean J pain 34(1):47\u201357","journal-title":"Korean J pain"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02349-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02349-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:07:26Z","timestamp":1787929646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02349-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02349-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}